Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Apr;33(4):1571-8.
doi: 10.3892/or.2015.3799. Epub 2015 Feb 13.

MicroRNAs in renal cell carcinoma: a systematic review of clinical implications (Review)

Ming Li  1 , Ying Wang  2 , Yongsheng Song  1 , Renge Bu  1 , Bo Yin  1 , Xiang Fei  1 , Qizhen Guo  1 , Bin Wu  1
Affiliations

MicroRNAs in renal cell carcinoma: a systematic review of clinical implications (Review)

Ming Li et al. Oncol Rep. 2015 Apr.

Abstract

Despite recent advances in the understanding of the biology of renal cell carcinoma (RCC), successful surgical treatment and implementation of novel‑targeted therapies, the prognosis for RCC patients remains poor. Late presentation, tumor heterogeneity and in particular the lack of molecular biomarkers for early detection, classification and the surveillance of RCC treatments are major obstacles. The increasing knowledge regarding the functional role of microRNAs (miRNAs) in pathophysiological processes may provide an important link to the identification of suitable therapeutic targets and diagnostic/prognostic biomarkers for RCC. The aim of this review was to provide new insight into the function of miRNAs in the pathogenesis of RCC and to emphasize their potential as diagnostic and prognostic markers, as well as therapeutic targets.

PubMed Disclaimer

Figures

Figure 1
Figure 1
microRNA biogenesis and processing mechanism.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Siegel R, Ma J, Zou Z, Jemal A. Cancer statistics, 2014. CA Cancer J Clin. 2014;64:9–29. doi: 10.3322/caac.21208. - DOI - PubMed
    1. Cohen HT, McGovern FJ. Renal-cell carcinoma. N Engl J Med. 2005;353:2477–2490. doi: 10.1056/NEJMra043172. - DOI - PubMed
    1. Rini BI, Rathmell WK, Godley P. Renal cell carcinoma. Curr Opin Oncol. 2008;20:300–306. doi: 10.1097/CCO.0b013e3282f9782b. - DOI - PubMed
    1. Janzen NK, Kim HL, Figlin RA, Belldegrun AS. Surveillance after radical or partial nephrectomy for localized renal cell carcinoma and management of recurrent disease. Urol Clin North Am. 2003;30:843–852. doi: 10.1016/S0094-0143(03)00056-9. - DOI - PubMed
    1. Bullock A, McDermott DF, Atkins MB. Management of metastatic renal cell carcinoma in patients with poor prognosis. Cancer Manag Res. 2010;2:123–132. - PMC - PubMed

Publication types

MeSH terms